ArticleJournal of translational medicine2025

NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy.

Shashanka Shekhar Sarkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.